Paper38482003
IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function.
Zhao H and 7 others. Front Immunol, 2024. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function. Papers, record 38482003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38482003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Psoriasis | Major topic |
| Microbiota | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Interleukin-17 | |
| Longitudinal Studies | |
| Case-Control Studies | |
| RNA, Ribosomal, 16S | |
| Bacteria | |
| Homeostasis |
Source PubMed
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31549347 | Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment. | Clin Drug Investig | 2019 | https://conductscience.org/library/papers/31549347 | PubMed |
| 2 | 32415989 | Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis. | Clin Exp Immunol | 2020 | https://conductscience.org/library/papers/32415989 | PubMed |
| 3 | 22571556 | A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis. | Australas J Dermatol | 2012 | https://conductscience.org/library/papers/22571556 | PubMed |
| 4 | 29559344 | Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial. | J Invest Dermatol | 2018 | https://conductscience.org/library/papers/29559344 | PubMed |
| 5 | 23521130 | Is chronic plaque psoriasis triggered by microbiota in the skin? | Br J Dermatol | 2013 | https://conductscience.org/library/papers/23521130 | PubMed |
| 6 | 35214702 | The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis? | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35214702 | PubMed |
| 7 | 32545459 | Gut Microbiome in Psoriasis: An Updated Review. | Pathogens | 2020 | https://conductscience.org/library/papers/32545459 | PubMed |
| 8 | 32860635 | Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population. | J Dermatol | 2021 | https://conductscience.org/library/papers/32860635 | PubMed |
| 9 | 28012235 | A safflower oil based high-fat/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation. | Mol Nutr Food Res | 2017 | https://conductscience.org/library/papers/28012235 | PubMed |
| 10 | 23685373 | Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. | Benef Microbes | 2014 | https://conductscience.org/library/papers/23685373 | PubMed |
| 11 | 34755891 | PASI vs PO-PASI: Patient-Oriented PASI (PO-PASI) is comparable to clinician score PASI. | Australas J Dermatol | 2022 | https://conductscience.org/library/papers/34755891 | PubMed |
| 12 | 34233192 | Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells. | Cell Rep | 2021 | https://conductscience.org/library/papers/34233192 | PubMed |
| 13 | 22699609 | Structure, function and diversity of the healthy human microbiome. | Nature | 2012 | https://conductscience.org/library/papers/22699609 | PubMed |
| 14 | 29454560 | Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood. | J Invest Dermatol | 2018 | https://conductscience.org/library/papers/29454560 | PubMed |
| 15 | 30238519 | Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients. | Exp Dermatol | 2018 | https://conductscience.org/library/papers/30238519 | PubMed |
| 16 | 10894962 | Apoptosis in established and healing psoriasis. | Dermatology | 2000 | https://conductscience.org/library/papers/10894962 | PubMed |
| 17 | 27050731 | New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. | Autoimmunity | 2016 | https://conductscience.org/library/papers/27050731 | PubMed |
| 18 | 32835590 | Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. | Gut Microbes | 2020 | https://conductscience.org/library/papers/32835590 | PubMed |
| 19 | 36145063 | Short Chain Fatty Acids (SCFAs) Are the Potential Immunomodulatory Metabolites in Controlling Staphylococcus aureus-Mediated Mastitis. | Nutrients | 2022 | https://conductscience.org/library/papers/36145063 | PubMed |
| 20 | 37207807 | Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell-Driven IL-17 Signature. | J Invest Dermatol | 2023 | https://conductscience.org/library/papers/37207807 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42496842 | Therapeutic potential of polygonatum polysaccharides in modulating gut microbiota and alleviating psoriasis-like inflammation in a mouse model. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42496842 | PubMed |
| 42151128 | Gut microbiota-induced perturbation in bile acids alter keratinocyte lipid metabolism via FXR-NQO1 signaling in psoriasis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42151128 | PubMed |
| 41900935 | Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41900935 | PubMed |
| 41795861 | The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review. | Exp Dermatol | 2026 | https://conductscience.org/library/papers/41795861 | PubMed |
| 41487796 | Efficacy of Probiotic Supplementation in the Management of Psoriasis: A Systematic Review. | Cureus | 2025 | https://conductscience.org/library/papers/41487796 | PubMed |
| 41321593 | Clinical Treatment and Clinical Application Research Progress of Psoriasis and Intestinal Microbiota Dysbiosis. | Clin Cosmet Investig Dermatol | 2025 | https://conductscience.org/library/papers/41321593 | PubMed |
| 41302127 | Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41302127 | PubMed |
| 40708005 | IL-17A inhibitors modulate skin microbiome in psoriasis: implications for microbial homeostasis. | J Transl Med | 2025 | https://conductscience.org/library/papers/40708005 | PubMed |
| 40333159 | Characterization of the Gut Microbiota in Patients with Psoriasis: A Systematic Review. | Pathogens | 2025 | https://conductscience.org/library/papers/40333159 | PubMed |
| 40161116 | Emerging Novel Therapies for the Treatment of Psoriasis: A Narrative Review. | Cureus | 2025 | https://conductscience.org/library/papers/40161116 | PubMed |
| 39582772 | The interplay between epidermal barrier distribution, microbiota composition, and immune infiltrate defines and stratifies psoriasis patients and is associated with disease severity. | J Transl Autoimmun | 2024 | https://conductscience.org/library/papers/39582772 | PubMed |
| 39328313 | The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39328313 | PubMed |
| 39170985 | Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39170985 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| SRA | 1078442 |
Source SRA
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38482003
GET https://conductscience.org/api/papers/v1/38482003/references?page=2